Biodegradable polymeric hydroxamic acids for the elimination of iron from the body

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Pharmaceutical Chemistry Journal

• Publication date

  1994-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02218993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.

  1989cited by this paper
• Iron-chelating therapy.

  1988cited by this paper
• Why deferoxamine therapy predisposes to Yersinia sepsis.

  1987cited by this paper
• High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis

  1986cited by this paper
• Extraction-spectrophotometric determination of iron as the ternary tris(1,10-phenanthroline)-iron(II)-picrate complex

  1985cited by this paper
• Ocular toxicity of desferrioxamine.

  1985cited by this paper
• Water‐insoluble dextrans by grafting, 2. Reaction of dextrans with n‐alkyl chloroformates. Chemical and enzymatic hydrolysis

  1985cited by this paper
• The selection and evaluation of new chelating agents for the treatment of iron overload.

  1979cited by this paper
• Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

  1979cited by this paper
• Letter: Exploration of the common bileduct.

  1974cited by this paper

• THERAPEUTIC ADVANCEMENTS IN MANAGEMENT OF IRON OVERLOAD-A REVIEW Review Article

  2015cites this paper